Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1974 3
1984 1
1985 1
1987 1
1988 1
1989 1
1990 3
1991 1
1992 3
1993 2
1995 3
1996 3
1997 3
1998 1
1999 3
2000 4
2001 3
2002 3
2003 4
2004 6
2005 1
2006 7
2008 5
2009 5
2010 7
2011 13
2012 6
2013 5
2014 6
2015 6
2016 7
2017 4
2018 1
2019 2
2020 3
2021 7
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial.
de Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, Hanssen N, Attaye I, Bakker G, Duinkerken G, Joosten A, Prodan A, Levin E, Levels H, Potter van Loon B, van Bon A, Brouwer C, van Dam S, Simsek S, van Raalte D, Stam F, Gerdes V, Hoogma R, Diekman M, Gerding M, Rustemeijer C, de Bakker B, Hoekstra J, Zwinderman A, Bergman J, Holleman F, Piemonti L, De Vos W, Roep B, Nieuwdorp M. de Groot P, et al. Among authors: van bon a. Gut. 2021 Jan;70(1):92-105. doi: 10.1136/gutjnl-2020-322630. Epub 2020 Oct 26. Gut. 2021. PMID: 33106354 Free PMC article. Clinical Trial.
Type I interferon as a stimulus for cross-priming.
Le Bon A, Tough DF. Le Bon A, et al. Cytokine Growth Factor Rev. 2008 Feb;19(1):33-40. doi: 10.1016/j.cytogfr.2007.10.007. Cytokine Growth Factor Rev. 2008. PMID: 18068417 Review.
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death.
Keller M, Yang S, Ponor L, Bon A, Cochrane A, Philogene M, Bush E, Shah P, Mathew J, Brown AW, Kong H, Charya A, Luikart H, Nathan SD, Khush KK, Jang M, Agbor-Enoh S. Keller M, et al. Among authors: bon a. Am J Transplant. 2023 Apr;23(4):559-564. doi: 10.1016/j.ajt.2022.12.019. Epub 2023 Jan 19. Am J Transplant. 2023. PMID: 36732088 Free PMC article.
Direct effects of type I interferons on cells of the immune system.
Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Hervas-Stubbs S, et al. Among authors: le bon a. Clin Cancer Res. 2011 May 1;17(9):2619-27. doi: 10.1158/1078-0432.CCR-10-1114. Epub 2011 Mar 3. Clin Cancer Res. 2011. PMID: 21372217 Free article. Review.
135 results